Hormone therapy increases risk of lung cancer death
Continued analysis of the Women's Health Initiative, a population study on women's health, yielded more warnings about hormone therapy." Hormone therapy, prescribed to ease the symptoms of menopause, has already been implicated as contributed to breast cancer.
Women near menopause who smoke or previously smoked and are considering hormone therapy should consult their physicians regarding this information.
From cancerfacts.com
ORLANDO – June 2, 2009 – Women with non-small cell lung cancer who take hormones to ease menopausal symptoms have an increased risk of dying from their cancer than women who don't take hormones, say researchers.
Led by Dr. Rowan Chlebowski, a medical oncologist at the Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center, researchers showed at the recently completed annual meeting of the American Society of Clinical Oncologists that use of hormone therapy that contains estrogen plus progestin increases the risk of dying in women with non-small cell lung cancer.
"Many women entering menopause have symptoms that make them consider hormone therapy," Chlebowski said in a prepared statement. "We already know that combined hormone therapy has more risks than benefits, including a higher risk of stroke and breast cancer, the most common cancer in U.S. women.
